نتایج جستجو برای: 1 vegfr

تعداد نتایج: 2754191  

Journal: :Cancer research 2011
Natasha Y Frank Tobias Schatton Soo Kim Qian Zhan Brian J Wilson Jie Ma Karim R Saab Veronika Osherov Hans R Widlund Martin Gasser Ana-Maria Waaga-Gasser Thomas S Kupper George F Murphy Markus H Frank

Melanoma growth is driven by malignant melanoma-initiating cells (MMIC) identified by expression of the ATP-binding cassette (ABC) member ABCB5. ABCB5(+) melanoma subpopulations have been shown to overexpress the vasculogenic differentiation markers CD144 (VE-cadherin) and TIE1 and are associated with CD31(-) vasculogenic mimicry (VM), an established biomarker associated with increased patient ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Jenny Yao Xiumin Wu Guanglei Zhuang Ian M Kasman Tobias Vogt Vernon Phan Masabumi Shibuya Napoleone Ferrara Carlos Bais

PlGF, one of the ligands for VEGFR-1, has been implicated in tumor angiogenesis. However, more recent studies indicate that genetic or pharmacological inhibition of PlGF signaling does not result in reduction of microvascular density in a variety of tumor models. Here we screened 12 human tumor cell lines and identified 3 that are growth inhibited by anti-PlGF antibodies in vivo. We found that ...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2008
Vadim Tchaikovski Guido Fellbrich Johannes Waltenberger

OBJECTIVE Arteriogenesis, the growth of preexisting arterioles into functional arteries, is dependent on the proper function of monocytes. Likewise, wound healing is monocyte-dependent. The activation of vascular endothelial growth factor receptor-1 (VEGFR-1) in monocytes induces a chemotactic response, triggers the expression of tissue factor, and gene expression of cytokines and chemokines. L...

Journal: :Cancer research 2005
Loïc Vincent David K Jin Matthias A Karajannis Koji Shido Andrea T Hooper William K Rashbaum Bronislaw Pytowski Yan Wu Daniel J Hicklin Zhenping Zhu Peter Bohlen Ruben Niesvizky Shahin Rafii

Induction of neoangiogenesis plays an important role in the pathogenesis of multiple myeloma. However, the mechanism by which expression of vascular endothelial growth factor (VEGF)-A and its receptors modulate the interaction of multiple myeloma cells with stromal cells is not known. Here, we describe a novel in vitro coculture system using fetal bone stromal cells as a feeder layer, which fac...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2005
Rima Dardik Joseph Loscalzo Regina Eskaraev Aida Inbal

OBJECTIVE Coagulation Factor XIII (FXIII) was previously shown by us to induce angiogenesis. The aim of this study was to elucidate the molecular events underlying the proangiogenic effects of activated FXIII (FXIIIa) on human umbilical vein endothelial cells (HUVECs). METHODS AND RESULTS As shown by coimmunoprecipitation studies, FXIIIa crosslinked alpha(v)beta3 with vascular endothelial gro...

Journal: :Clinical and experimental rheumatology 2008
J Salo A Kaigle Holm A Indahl Z Mackiewicz A Sukura S Holm E Jämsen Y T Konttinen

OBJECTIVE To analyze immunohistochemically the localization of the VEGF receptors in experimental intervertebral disc degeneration tissues in a pig model. MATERIALS AND METHODS In six domestic pigs, the cranial bony endplate of the L4 vertebra were perforated into the nucleus pulposus. Three months postoperatively, the animals were sacrificed and the experimental and control vertebrae, comple...

Journal: :Molecular cancer therapeutics 2011
Jane Kendrew Cath Eberlein Brad Hedberg Karen McDaid Neil R Smith Hazel M Weir Stephen R Wedge David C Blakey Ian Foltz Joe Zhou Jaspal S Kang Simon T Barry

Inhibition of VEGFR-2 signaling reduces angiogenesis and retards tumor growth. Current biotherapeutics that inhibit VEGFR-2 signaling by either sequestering VEGF ligand or inhibiting VEGF binding to VEGFR-2 may be compromised by high VEGF concentrations. Here we describe a biotherapeutic that targets VEGFR-2 signaling by binding to Ig domains 4-7 of VEGFR-2 and therefore has the potential to wo...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Roberto Bianco Roberta Rosa Vincenzo Damiano Gennaro Daniele Teresa Gelardi Sonia Garofalo Valeria Tarallo Sandro De Falco Davide Melisi Roberto Benelli Adriana Albini Anderson Ryan Fortunato Ciardiello Giampaolo Tortora

PURPOSE The resistance to selective EGFR inhibitors involves the activation of alternative signaling pathways, and Akt activation and VEGF induction have been described in EGFR inhibitor-resistant tumors. Combined inhibition of EGFR and other signaling proteins has become a successful therapeutic approach, stimulating the search for further determinants of resistance as basis for novel therapeu...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2016
Joao Incio Josh Tam Nuh N Rahbari Priya Suboj Dan T McManus Shan M Chin Trupti D Vardam Ana Batista Suboj Babykutty Keehoon Jung Anna Khachatryan Tai Hato Jennifer A Ligibel Ian E Krop Stefan B Puchner Christopher L Schlett Udo Hoffmman Marek Ancukiewicz Masabumi Shibuya Peter Carmeliet Raquel Soares Dan G Duda Rakesh K Jain Dai Fukumura

PURPOSE Obesity promotes pancreatic and breast cancer progression via mechanisms that are poorly understood. Although obesity is associated with increased systemic levels of placental growth factor (PlGF), the role of PlGF in obesity-induced tumor progression is not known. PlGF and its receptor VEGFR-1 have been shown to modulate tumor angiogenesis and promote tumor-associated macrophage (TAM) ...

Journal: :Molecular biology of the cell 1999
N Rahimi A Kazlauskas

FLK-1/vascular endothelial growth factor receptor 2 (VEGFR-2) is one of the receptors for VEGF. In this study we examined the effect of cell density on activation of VEGFR-2. VEGF induces only very slight tyrosine phosphorylation of VEGFR-2 in confluent (95-100% confluent) pig aortic endothelial (PAE) cells. In contrast, robust VEGF-dependent tyrosine phosphorylation of VEGFR-2 was observed in ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید